Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biosyent Inc. (RX.VN)

Biosyent Inc. (RX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biosyent Inc. 2476 Argentia Road Suite 402 Mississauga ON L5N 6M1 CAN

www.biosyent.com P: 905-206-0013 F: 905-206-1413

Sector:

Medical

Description:

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.

Key Statistics

Overview:

Market Capitalization, $K 170,967
Shares Outstanding, K 11,497
% of Institutional Shareholders 12.95%

Financials:

Annual Sales, $ 43,052 K
Annual Net Income, $ 9,012 K
Last Quarter Sales, $ 9,672 K
Last Quarter Net Income, $ 1,992 K

Growth:

1-Year Return 36.80%
3-Year Return 95.92%
5-Year Return 96.95%
5-Year Revenue Growth 14.03%
5-Year Earnings Growth 21.98%

Per-Share Information:

Most Recent Earnings 0.18 on 03/19/26
Next Earnings Date 05/21/26
Earnings Per Share ttm 0.78
EPS Growth vs. Prev Qtr -24.10%
EPS Growth vs. Prev Year 27.73%
Annual Dividend & Yield (Paid) 0.20 (1.48%)
Annual Dividend & Yield (Fwd) 0.22 (1.48%)
Most Recent Dividend 0.055 on 02/27/26
Next Ex-Dividends Date 02/27/26
Dividend Payable Date 03/13/26
Dividend Payout Ratio 25.54%

RX.VN Ratios

Ratio
Price/Earnings ttm 18.99
Price/Earnings forward 15.82
Price/Earnings to Growth N/A
Return-on-Equity % 23.57%
Return-on-Assets % 19.85%
Profit Margin % 20.93%
Debt/Equity 0.02
Price/Sales 3.97
Price/Book 4.12
Book Value/Share 3.61

RX.VN Dividends

Date Value
02/27/26 $0.0550
11/28/25 $0.0500
08/29/25 $0.0500
05/30/25 $0.0500
02/28/25 $0.0500
11/29/24 $0.0450
09/04/24 $0.0450
05/31/24 $0.0450
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.